Le Lézard
Classified in: Health
Subjects: CHI, PER, DEI

Cincinnati Children's names Bob Carpenter senior vice president and chief legal officer


CINCINNATI, Feb. 27, 2024 /PRNewswire/ -- Cincinnati Children's has named Bob Carpenter senior vice president and chief legal officer. He had served in the role on an interim basis since Feb. 2. 

"Bob is a trusted leader with proven expertise in corporate governance, risk management, litigation and compliance."

An employee of the health system since 2006, Carpenter joins the 11-person Executive Team led by Steve Davis, MD, president and chief executive officer of Cincinnati Children's. 

"Bob is a trusted leader with proven expertise in corporate governance, risk management, litigation and compliance," Davis said. "His exemplary performance, deep identification with our mission, and collaborative approach to problem solving make him ideally suited to excel in this role. Additionally, his career journey at Cincinnati Children's is a great example of our investment in attracting, developing and retaining great talent." 

During his tenure at Cincinnati Children's, Carpenter has effectively managed the Healthcare Professional Liability Program and served as lead internal counsel for multiple rounds of bond financing, achieving best-in-class results.

Carpenter initiated and led the Enterprise Risk Management Program, including oversight of the biennial risk assessment process. He standardized the centralized professional practice evaluation program and played a key role in identifying and recruiting professional practice leadership. 

Carpenter earned a bachelor's degree in history from Hanover College in 1992 and a juris doctor degree in 1995 from the University of Cincinnati College of Law. A Cincinnati native, he lives in Madeira with his wife and their two sons.

He succeeds Rosland Fisher McLeod, who recently left after having been chief legal officer since 2022. 

About Cincinnati Children's
Cincinnati Children's ranks No. 1 in the nation in U.S. News & World Report's?2023-24 listing of Best Children's Hospitals. Every year, the health system serves patients and families from all 50 states and dozens of countries. About one-third of the organization's nearly 19,000 employees are engaged in research, and Cincinnati Children's is recognized as one of America's Most Innovative Companies by Fortune. Established in 1883, Cincinnati Children's is a nonprofit academic organization that is internationally recognized for improving child health and transforming delivery of care through research, education, and innovation. Additional information may be found at?CincinnatiChildrens.org. 

SOURCE Cincinnati Children's Hospital Medical Center


These press releases may also interest you

at 21:10
Aurora Spine Corporation ("Aurora Spine" or the "Company") , a leader in spine and interventional spine technology that improves spinal surgery outcomes, today announced its financial results for first quarter ended March 31, 2024. All figures...

at 20:43
PAVmed Inc.  ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today provided a business...

at 20:35
Cue Health Inc. , a healthcare technology company (the "Company"), has received a warning letter from the FDA about its Emergency Use Authorized (EUA) COVID-19 test. The Company is currently evaluating the letter and determining its response, with...

at 19:35
CV Sciences, Inc.  (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced that it has consummated...

at 19:32
Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today that the first patients with diabetic retinopathy...

at 19:21
Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet need, today announced that the Center for Drug...



News published on and distributed by: